Feasibility of Implementing a Comprehensive Warfarin Pharmacogenetics Service

Strategies for Personalized Medicine–Based Research and Implementation in the Clinical Workflow

(2012) W Lieb et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Implementing Personalized Medicine: Development of a Cost-Effective Customized Pharmacogenetics Genotyping Array

(2012) J A Johnson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis

(2012) Andrea L. Jorgensen et al.   PLoS One

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing

(2011) J A Johnson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genetic Warfarin Dosing

(2011) Brian S. Finkelman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Emergency Hospitalizations for Adverse Drug Events in Older Americans

(2011) Daniel S. Budnitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of Apolipoprotein E Genotype with Duration of Time to Achieve a Stable Warfarin Dose in African-American Patients

(2011) Larisa H Cavallari et al.   PHARMACOTHERAPY

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy

(2011) Petra Lenzini et al.   THROMBOSIS AND HAEMOSTASIS

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

(2010) P Lenzini et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose

(2009) Fumihiko Takeuchi et al.   PLoS Genetics

CYP4F2 genetic variant alters required warfarin dose

(2008) M. D. Caldwell et al.   BLOOD

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

(2008) G. M. Cooper et al.   BLOOD

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

(2008) BF Gage et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS